BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 17214344)

  • 21. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parathyroid carcinoma: challenges in diagnosis and treatment.
    Mohebati A; Shaha A; Shah J
    Hematol Oncol Clin North Am; 2012 Dec; 26(6):1221-38. PubMed ID: 23116578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional parathyroid carcinoma: Long-term treatment outcome and risk factor analysis.
    Iihara M; Okamoto T; Suzuki R; Kawamata A; Nishikawa T; Kobayashi M; Obara T
    Surgery; 2007 Dec; 142(6):936-43; discussion 943.e1. PubMed ID: 18063079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Surgery for pancreatic cancer].
    Welsch T; Büchler MW; Schmidt J
    Z Gastroenterol; 2008 Dec; 46(12):1393-403. PubMed ID: 19053009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term outcome of patients with elevated parathyroid hormone levels after successful parathyroidectomy for sporadic primary hyperparathyroidism.
    Solorzano CC; Mendez W; Lew JI; Rodgers SE; Montano R; Carneiro-Pla DM; Irvin GL
    Arch Surg; 2008 Jul; 143(7):659-63; discussion 663. PubMed ID: 18645108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hurthle cell neoplasm of the thyroid gland.
    Ahmed M; Bin Yousef H; Greer W; Faraz H; Al Sobhi S; Al Zahrani A; Raef H; Al Ghamdi A; Al Kadhi Y; Al Dayel F
    ANZ J Surg; 2008 Mar; 78(3):139-43. PubMed ID: 18269475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: a review of the literature.
    Gadducci A; Tana R; Cosio S; Genazzani AR
    Crit Rev Oncol Hematol; 2008 Apr; 66(1):10-20. PubMed ID: 17964182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does histopathology predict parathyroid hypersecretion and influence correctly the extent of parathyroidectomy in patients with sporadic primary hyperparathyroidism?
    Carneiro-Pla DM; Romaguera R; Nadji M; Lew JI; Solorzano CC; Irvin GL
    Surgery; 2007 Dec; 142(6):930-5; discussion 930-5. PubMed ID: 18063078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fetal and neonatal hepatic tumors.
    Isaacs H
    J Pediatr Surg; 2007 Nov; 42(11):1797-803. PubMed ID: 18022426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful palliation of hypercalcemia secondary to metastatic parathyroid cancer: an unusual indication for hepatic resection.
    Mezhir JJ; Melis M; Headley RC; Pai RK; Posner MC; Kaplan EL
    J Hepatobiliary Pancreat Surg; 2007; 14(4):410-3. PubMed ID: 17653642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High third generation/second generation PTH ratio in a patient with parathyroid carcinoma: clinical utility of third generation/second generation PTH ratio in patients with primary hyperparathyroidism.
    Caron P; Maiza JC; Renaud C; Cormier C; Barres BH; Souberbielle JC
    Clin Endocrinol (Oxf); 2009 Apr; 70(4):533-8. PubMed ID: 18782355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spontaneous rupture of hepatocellular carcinoma: a Western experience.
    Battula N; Madanur M; Priest O; Srinivasan P; O'Grady J; Heneghan MA; Bowles M; Muiesan P; Heaton N; Rela M
    Am J Surg; 2009 Feb; 197(2):164-7. PubMed ID: 18926518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A case of resistant hypercalcemia of malignancy with a proposed treatment algorithm.
    McMahan J; Linneman T
    Ann Pharmacother; 2009 Sep; 43(9):1532-8. PubMed ID: 19622757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parathyroid carcinoma.
    Goswamy J; Lei M; Simo R
    Curr Opin Otolaryngol Head Neck Surg; 2016 Apr; 24(2):155-62. PubMed ID: 26771263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Repeat retroperitoneal lymph-node dissection after chemotherapy for metastatic testicular germ cell tumour.
    Willis SF; Winkler M; Savage P; Seckl MJ; Christmas TJ
    BJU Int; 2007 Oct; 100(4):809-12. PubMed ID: 17711512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Medullary thyroid carcinoma and some of its particularities].
    Sidibé el H
    Sante; 2007; 17(1):51-5. PubMed ID: 17897902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The clinical utility of parathyroid hormone-related peptide in the assessment of hypercalcemia.
    Fritchie K; Zedek D; Grenache DG
    Clin Chim Acta; 2009 Apr; 402(1-2):146-9. PubMed ID: 19168044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diagnosis and surgical treatment of 48 cases of parathyroid adenoma and parathyroid carcinoma].
    Yang ZQ; Zhu LW; Wang PZ
    Zhonghua Zhong Liu Za Zhi; 2006 Aug; 28(8):625-7. PubMed ID: 17236561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of clodronate, pamidronate, and zoledronate in reducing morbidity and mortality in cancer patients with bone metastasis: a meta-analysis of randomized clinical trials.
    Machado M; Cruz LS; Tannus G; Fonseca M
    Clin Ther; 2009 May; 31(5):962-79. PubMed ID: 19539097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.